Asahi Kasei Introduces MOTIV Buffer Management

MOTIV is designed to keep pharmaceutical production moving efficiently and precisely.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Asahi Kasei Bioprocess, subsidiary of Japanese technology company Asahi Kasei showcased it MOTIV Buffer Management Technology at ACHEMA 2022 in Frankfurt in August. Using built-in automation software, MOTIV is designed to keep pharmaceutical production moving efficiently and precisely, so that medicine can be produced in larger quantities and be made more available globally.   Buffers are used for the vast majority of processes in pharmaceutical development, which has traditionally require...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters